An array of behavioral (motor and non-motor) and biochemistry analyses (stereological analysis of TH-positive neurons, HPLC analysis of DA, DOPAC and HVA levels, autoradiographic evaluation of [3H]FE-PE2I binding to DAT, and western blot studies on key proteins associated with PD) was conducted. The gene discussed is SLC6A3; the disease is Parkinson disease.